News from kowa company, ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 17, 2013, 11:30 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia

Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE: LLY) announced results of a pre-specified safety analysis from the INTREPID...

Mar 07, 2013, 06:30 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

New Superiority Trial Showed LIVALO® (pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults with Dyslipidemia versus Pravastatin 40 mg

Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE:LLY) announced results of a study evaluating the efficacy of...

Nov 14, 2012, 03:00 ET

Los médicos piden una mejor guía sobre el uso de las estatinas en pacientes con alto riesgo de desarrollar diabetes

En el Día mundial de la diabetes, los resultados de una consulta a médicos, entre ellos cardiólogos y expertos en diabetes,...

Nov 14, 2012, 03:00 ET

Les médecins appellent à une amélioration des consignes sur l'utilisation des statines chez les patients à risque élevé de développer un diabète

À l'occasion de la Journée mondiale du diabète, les résultats d'une consultation effectuée auprès de médecins,...

Nov 14, 2012, 03:00 ET

Ärzte fordern bessere Anleitung zum Einsatz von Statinen bei Patienten mit hohem Risiko für die Entwicklung von Diabetes

Am Weltdiabetestag zeigen die Ergebnisse von Beratungen mit Ärzten, darunter Kardiologen und Diabetologen, während des "World Congress...

Nov 05, 2012, 11:00 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

Results from the Largest Known Cholesterol Survey Conducted in the U.S. Announced at the American Heart Association's Annual Scientific Sessions

Results from the USAGE survey, the largest known cholesterol survey in the U.S. involving more than 10,100 statin users1, were presented today at...

Jul 22, 2012, 15:00 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

Pharmacokinetic Study Results Released Evaluating Interactions Between LIVALO® (pitavastatin) and Protease Inhibitor Combination (darunavir/ritonavir) in Healthy Volunteers

Kowa Pharmaceuticals America, Inc. (Kowa Pharmaceuticals) and Eli Lilly and Company (Lilly) (NYSE: LLY) today released results from a...

Jun 13, 2012, 14:20 ET
Jun 13, 2012, 12:16 ET

La reducción de LDL-C de la pitavastatina es equivalente a otras estatinas

- La reducción de LDL-C de la pitavastatina es equivalente a otras estatinas pero el efecto en HDL-C y los triglicéridos es superior,...

Jun 13, 2012, 10:39 ET

Pitavastatin bei LDL-C-Senkung äquivalent mit anderen Statinen, aber bei Wirkung auf HDL-C und Triglyzeride überlegen, zeigt Durchsicht von Primärveröffentlichungen

Mit zwei Beiträgen im European Journal of Preventive Cardiology (1,2) wird die Veröffentlichung der Daten aus dem Entwicklungsprogramm...

May 31, 2012, 06:00 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction When Compared with Pravastatin

Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE:LLY) today announced results of the PREVAIL U.S. study (Pitavastatin compaREd...

Jun 21, 2010, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Kowa Pharmaceuticals America and Lilly Announce U.S. Availability of LIVALO

Kowa Pharmaceuticals America, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that LIVALO® (pitavastatin) tablets is now...

Oct 22, 2009, 08:00 ET

Study Demonstrates LIVALO(R) Is an Efficacious Treatment for Achieving Lipid Goals

New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO...

Sep 02, 2009, 07:09 ET

Study Shows LIVALO(R) is not Affected by Co-Administration of Itraconazole

LIVALO (pitavastatin) may have the potential for fewer drug-drug interactions, versus other statins, as evidenced by a new study that...

Sep 01, 2009, 08:43 ET

LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

New data presented today showed that in patients treated with LIVALO (pitavastatin), high-density lipoprotein cholesterol (HDL-C) concentrations...

Jun 16, 2009, 08:00 ET

Study Demonstrates Efficacy of Pitavastatin in Elderly Patients

Pitavastatin represents important treatment option for more vulnerable populations New data presented today showed that pitavastatin is an...

Jun 15, 2009, 08:00 ET

Pitavastatin Demonstrates Promise for Low Incidence of Drug-Drug Interaction

Study shows Kowa's novel synthetic statin is safe and well tolerated in combination with warfarin New data presented today showed that...